Accelmed is a global investment firm focused on providing investments in small and mid-cap private and public companies. The Firm looks to invest between $20 and $50 million in medical device companies and technologies with revenues greater than $30 million. Prospective transaction types include management buyouts and growth financings. Accelmed was formed in 2009 and is based in New York City.


M&A Summary

Buy vs Sell

Top M&A Advisors

Join Mergr to view the latest updates and news from Accelmed.

Accelmed’s most common sector for investment is software (100%). The Firm’s most common investment types include secondary buyout (100%). In total, Accelmed has invested in 1 US state.

Join Mergr to view Accelmed’s full profile and discover more small private equity firms just like it.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.5K Private Equity Firms
  • 124K M&A Transactions
  • 133K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.9K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.